Idiopathic Thrombocytopenic Purpura Tied to Higher CVD Risk
Risk further increased among patients with ITP who undergo splenectomy
For Hospitals, No Benefit for Early Adoption of Financial Incentives
Hospitals with early adoption do not have better process scores, lower mortality than late adopters
Cancer Death Rate Continuing to Decline in United States
Continuous drop in combined cancer death rate from 1991 to 2015, resulting in 2,378,600 fewer deaths
Fluorouracil Tied to Reduced Surgery for Squamous Cell CA
Reduced risk of squamous cell carcinoma, but not basal cell carcinoma, for one year in at-risk veterans
Breast Implants Slightly Increase Risk of Breast ALCL
Implants tied to increased risk of anaplastic large-cell lymphoma; overall risk still very small
Immune-Related Adverse Events Up With Checkpoint Inhibitors
Most patients with cancer, autoimmune disease have improvement in events without discontinuing therapy
Few Immuno-Oncology Agents Reach ASCO Efficacy Thresholds
Durable survival, response rates rarely recognized as significant by current oncology value frameworks
HSPC-Derived CAR T-Cells Capable of Lasting Engraftment
Chimeric antigen receptor T-cells persisted more than 2 years without measurable toxicity in primate model
December 2017 Briefing – Hematology & Oncology
Here are what the editors at HealthDay consider to be the most important developments in Hematology & Oncology for December 2017. This roundup includes...
Same-Day, Low-Dose Bowel Prep Feasible for Colonoscopy
For inpatients at high risk of poor bowel prep, same-day 1-liter polyethylene glycol-based prep effective
